Stockreport

Capricor Therapeutics -2% on DMD trial halt [Seeking Alpha]

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF Capricor Therapeutics (NASDAQ: CAPR ) announces putting its Duchenne muscular dystrophy trial for lead drug CAP-1002 on hold after a safety review following a s [Read more]